SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C
http://www.w3.org/2000/01/rdf-schema#comment
"Synbindin contributes to malignant phenotypes of GC by activating ERK on the Golgi and synbindin is a potential biomarker and therapeutic target for GC."
xsd:string
http://purl.uniprot.org/uniprot/#_91C31019FFFF6B750BED93ABE14DF8BA63AC1B81235D0DA7BFC8565D76B96943811C92958CA93B953C0A89CAC330ED18
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C
http://purl.uniprot.org/uniprot/J3KP27
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C
http://purl.uniprot.org/uniprot/#_J3KP27-mappedCitation-24104608
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8173BF5A6939A0F9303B5F7C38B1BD0F4981D112C109BD4CDACC463EF4DFD4F115F2567F699AF83955736A77DEF7F31C